Loading clinical trials...
Loading clinical trials...
Consecutive patients treated with PD-1 therapy in Qingdao City were included in our study. The effecy and safety of the four PD-1 agents according to clinical outcomes in real world will be studied.
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
The Affiliated Hospital of Qingdao University
NCT05787561 · Mesonephric Gynecologic Cancer
NCT00242723 · Malignant Pleural Mesotheliomas NOS, Esophageal Cancers NOS, and more
NCT07447050 · Breast Cancer, Sarcoma, and more
NCT05521789 · Pulmonary Neoplasm, Pulmonary Cancer, and more
NCT07416630 · Gynecologic Cancer, Urologic Cancer, and more
The Affiliated Hospital of Qingdao University
Qingdao, Shandong
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions